Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q4 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.